Ovid Therapeutics (OVID) Share-based Compensation (QoQ) (2016 - 2026)
Ovid Therapeutics (OVID) Share-based Compensation (QoQ) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - |
| 2 | Nanobiotix | 1,913.50 Bn | 1,913.44 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 472.39 Bn | 467.60 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.08 Bn | 114.83 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.98 Bn | 61.22 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.97 Bn | 50.78 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.46 Bn | 959.66 Mn |
| 10 | Ovid Therapeutics | 120.41 Mn | -35.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.47% |
| Dec 31, 2025 | 7.75% |
| Sep 30, 2025 | -9.02% |
| Jun 30, 2025 | -5.06% |
| Mar 31, 2025 | 1.90% |
| Dec 31, 2024 | -3.67% |
| Sep 30, 2024 | -24.83% |
| Jun 30, 2024 | -11.59% |
| Mar 31, 2024 | 10.01% |
| Dec 31, 2023 | 9.69% |
| Sep 30, 2023 | -16.27% |
| Jun 30, 2023 | 1.62% |
| Sep 30, 2022 | 641.00% |
| Jun 30, 2022 | 29.85% |
| Sep 30, 2021 | -7.59% |
| Jun 30, 2021 | -4.75% |
| Mar 31, 2021 | -35.64% |
| Dec 31, 2020 | -21.61% |
| Sep 30, 2020 | 68.21% |
| Jun 30, 2020 | 19.37% |